Erratum: Stabilization of SMAR1 mRNA by PGA2 involves a stem-loop structure in the 5′ UTR (Nucleic Acids Research (2007) 35:18 (6004-6016) DOI: 10.1093/nar/gkm649);Stabilization of SMAR1 mRNA by PGA2 involves a stem-loop structure in the 5′ UTR

Nucleic Acids Research

Volumn 35, Issue 18, 2007, Pages 6004-6016

  Pavithra, Lakshminarasimhan ^a   Rampalli, Shravanti ^a,c   Sinha, Surajit ^a   Sreenath, Kadreppa ^a   Pestell, Richard G ^b   Chattopadhyay, Samit ^a  

^a NATIONAL CENTRE FOR CELL SCIENCE   (India)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; MATRIX ATTACHMENT REGION BINDING PROTEIN; MESSENGER RNA; NUCLEOPROTEIN; PROSTAGLANDIN A2; PROTEIN SMAR1; UNCLASSIFIED DRUG;

5' UNTRANSLATED REGION; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; COMPLEX FORMATION; DOWN REGULATION; DRUG TARGETING; GENE REPRESSION; GENE STRUCTURE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN TARGETING; REGULATORY MECHANISM; RNA STABILITY;

EID: 35548946206     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkac168     Document Type: Erratum

References (27)

1. Keene,J.D. and Tenenbaum,S.A. (2002) Eukaryotic mRNPs may represent posttranscriptional operons. Mol. Cell, 9, 1161-1167.
2. Ing,N.H. (2005) Steroid hormones regulate gene expression post-transcriptionally by altering the stabilities of messenger RNAs. Biol. Reprod., 72, 1290-1296.
3. Pagano,M., Tam,S.W., Theodoras,A.M., Beer-Romero,P., Del Sal,G., Chau,V., Yew,P.R., Draetta,G.F. and Rolfe,M. (1995) Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science, 269, 682-685.
4. Carlson,B., Lahusen,T., Singh,S., Loaiza-Perez,A., Worland,P. J., Pestell,R., Albanese,C., Sausville,E.A. and Senderowicz,A.M. (1999) Down-regulation of cyclin DI by transcriptional repression in MCF-7 human breast carcinoma cells induced by flavopiridol. Cancer Res., 59, 4634-4641.
5. Hsiang,C.H. and Straus,D.S. (2002) Cyclopentenone causes cell cycle arrest and represses cyclin DI promoter activity in MCF-7 breast cancer cells. Oncogene, 21, 2212-2226.
6. Fukushima,M., Sasaki,H. and Fukushima,S. (1994) Prostaglandin J2 and related compounds. Mode of action in G1 arrest and preclinical results. Ann. NY Acad. Sci., 744, 161-165.
7. Gorospe,M., Liu,Y., Xu,Q., Chrest,F.J. and Holbrook,N.J. (1996) Inhibition of G1 Cyclin-dependent kinase activity during growth arrest of human breast carcinoma cells by prostaglandin A2. Mol. Cell. Biol. 16, 762-770.
8. Lin,S., Wang,W., Wilson,G.M.,.Yang,X., Brewer,G., Holbrook,N.J. and Gorospe,M. (2000) Down-regulation of cyclin D1 expression by prostaglandin A (2) is mediated by enhanced cyclin D1 mRNA turnover. Mol. Cell. Biol., 20, 7903-7913.
9. Fan,J-, Yang,X., Wang,W., Wood,W.H., Becker,K.G. and Gorospe,M. (2002) Global analysis of stress-regulated mRNA turnover by using cDNA arrays. Proc. Natl Acad. Sci. USA, 92, 10611-10616.
10. Santoro,M.G. and Amici,C. (1987) Control of the growth of a human erythroleukemic cell line by prostaglandins. Adv. Prostaglandin Thromboxane Leukot. Res., 17B, 969-971.
11. Amici,C., Sistonen,L., Santoro,M.G. and Morimoto,R.I. (1992) Antiproliferative prostaglandins activate heat shock transcription factor. Proc. Natl Acad. Sci. USA, 89, 6227-6231.
12. Millard,S.S., Vidal,A., Markus,M. and Koff,A. (2000) A U-rich element in the 5′ untranslated region is necessary for the trinslation of p27 mRNA. Mol. Cell Biol., 20, 5947-5959.
13. Yang,X., Wang,W., Fan,J., Lal,A., Yang,D., Cheng,H. and Gorospe,M. (2004) Prostaglapdin A2-mediated stabilization of p2l mRNA through an ERK-dependent pathway requiring the RNA, binding protein HuR. J. Biol. Chem., 279, 49298-49306.
14. Rampalli,S., Pavithra,L., Dhatt,A., Kundu,T.K. and Chattopadhyay,S. (2005) Tumor suppressor SMAR1 mediates cyclin D1 repression by recruitment of the SIN3/histone-deacetylase 1 complex. Mol. Cell Biol., 25, 8415-8429.
15. Jalota,A., Singh,K., Pavithra,L., Jameel,S. and Chattopadhyay,S. (2005) Tumor suppressor SMARI activates and stabilizes p53 through its arginine-serine-rich motif. J. Biol. Chem., 280, 9450-9459.
16. Kaul,R., Mukherjee,S., Ahmed,F., Bhat,M.K.,, Chhipa,R., Galande,S. and Chattopadhyay;S. (2003) Direct interaction with and activation of p53 by SMAR1 retards cell-cycle progression at G2/M phase and delais tumor growth in mice. Int. J. Cancer, 103, 606-615.
17. Kaul-GhanekarR., Majumdar,S., Jalota,A., Gulati,N., Dubey,N., Saha,B. and Chattopadhyay,S. (2005) SMAR1 transgenice mice data. J. Biol. Chem., 280, 9450-9459.
18. Singh,K., Mogare,D., Giridharagopalan,R.O., Gogiraju,R., Pande,G. and Chattopadhyay,S. (2007) p53 Target Gene SMAR1 is dysregulated in breast cancer: Its role in cancer cell migration and invasion. PLoS ONE., 2, e660.
19. Chattopadhyay,S., Kaul,R., Charest,A., Housman,D. and Chen,J. (2000) SMAR1, a novel, alternatively spliced gene product, binds the Scaffold/ Matrix-associated region at the T cell receptor beta locus. Genomics 68, 93-96.
20. KlaffP., Riesner,D. and Steger,G. (19961 RNA structure and the regulation of gene expression. Plant Mol. Biol., 32, 89-106.
21. Zuker,M. (2003) Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res., 31, 3406-3415.
22. Bhuyan,B.K., Adams,E.G., Badiner,G.J., Li,L.H. and Barden,K. (1986) Cell cycle effects of prostaglandins Al, A2, and D2 in human and murine melanoma cells in culture. Cancer Res., 46, 1688-1693.
23. Ross,J. (1995) mRNA stability in mammalian cells. Microbiol. Rev., 59, 423-450.
24. Staton,J.M., Thomson,A.M. and Leedman,P.J. (2000) Hormonal regulation of mRNA stability and RNA-protein interactions in the pituitary. J. Mol. Endocrinol., 25, 17-34.
25. Audic,Y. and Hartley,R.S. (2004) Post-transcriptional regulation in cancer. Mol. Biol. Cell, 96, 479-498.
26. Liebhaber,S.A. (1997) mRNA stability and the control of gene expression. Nucleic Acids Symp. Ser., 36, 29-32.
27. Guiner,C., Lejeune,F., Galiana,D., Kister,L., Breathnach,R, Stevenin,J. and Konczak,F. (2001) TIA-1 and TIAR activate splicing of alternative exons with weak 5′ splice sites followed by a U-rich stretch on their own pre-mRNAs. J. Biol. Chem., 276, 40638-40646.